Gisele Dion, Director at Cytek Biosciences, Inc. (CTKB), bought 5,000 shares at $17.00 ($85K) on 2021-07-22, disclosed to the SEC on 2021-07-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.